Global Immunoassay Market Assessment, By Product [Reagents and Kits, Analyzers, Software and Services], By Technique [Enzyme-Linked Immunosorbent Assays, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Immuno-PCR, Other Techniques], By Specimen [Blood, Saliva, Urine, Others], By Application [Oncology, Cardiology, Therapeutic Drug Monitoring, Infectious Diseases, Endocrinology, Autoimmune Diseases, Others], By End-user [Hospitals, Clinical Laboratories, Pharmaceutical and Biotech Companies, Blood Banks, Others], By Region, Opportunities and Forecast, 2017-2031F
Global immunoassay market is being propelled by the rising prevalence of chronic and infectious diseases, growing geriatric population, advancements in technology, and government initiatives.
Home>Industry Reports>Global Immunoassay Market Assessment, Opportunities and Forecast, 2017-2031F
Global immunoassay market is projected to witness a CAGR of 4.8% during the forecast period 2024-2031, growing from USD 34.11 billion in 2023 to USD 49.63 billion in 2031. Growth in the global immunoassay market is driven by various factors such as the rising prevalence of chronic diseases and infectious diseases, the growing elderly population, technological advancements and innovations in the biotech industry, increased healthcare expenditure, and government initiatives.
The global immunoassay market is undergoing robust growth due to the growing prevalence of chronic diseases around the world, such as cardiovascular diseases, diabetes, and cancer. A sedentary lifestyle, unhealthy diet, and increasing alcohol and tobacco consumption are the main risk factors that are contributing to the growing number of patients with chronic diseases. An increasing number of infectious diseases are also accelerating the growth of the global immunoassay market, as immunoassay has an important role in detecting and monitoring several diseases. Increase in elderly population is one of the most common risk factors for chronic as well as infectious diseases, as elderly people are more prone to these diseases. Immunoassay is an important tool for accurate and fast diagnosis of these diseases in terms of screening and regular monitoring. To deliver high-quality medical care and upgrade healthcare facilities, governments are encouraging private companies to invest more in research and development (R&D) of more effective and efficient immunoassay platforms and technologies. Moreover, wide applications of immunoassay in different healthcare sectors like hospitals, clinics, biotechnology companies are significantly increasing the demand for immunoassay diagnostics.
Increasing Prevalence of Chronic and Infectious Diseases
The increasing prevalence of chronic and infectious diseases drives the global immunoassay market. As the incidence of these diseases continues to rise, there is a growing demand for immunoassays to diagnose and monitor various conditions. This has led to the development of innovative products and the adoption of immunoassay-based point-of-care (POC) testing and rapid testing. Immunoassay is used to diagnose a variety of infectious diseases, including chickenpox, dengue, ebola, influenza, and hepatitis. It is a valuable tool for detecting the presence of specific viruses, viral antigens, or antibodies in clinical specimens. Healthcare professionals can only effectively address this issue by guiding the appropriate treatment through early diagnosis and accurate detection of the disease and its causing agent.
For instance, rRT-PCR played a crucial role during SARS-CoV-2 infection, and it is expected that immunoassay will further be required in future pandemics. With growing burden of these diseases, demand for immunoassay is also increasing, facilitating growth of global immunoassay market.
Technological Advancements
Over the past few years, there has been a surge of favorable technological advancements in the biotechnology sector, which, in turn, has also led to innovation in the immunoassay market. With novel techniques and methods to improve the immunoassay's specificity, these advancements aim to improve the characteristics and potential of the test, which may ultimately lead to better disease diagnosis and treatment. For instance, an article titled "The advancement in nanotechnology and biotechnology", published in Biosensors journals in the year 2022, described the invention of a new type of nanomaterial with intrinsic enzyme-like characteristics known as “nanozymes[BD1]”. These nanozymes have different catalytic mechanisms, mimic enzymes, and can be designed as labels in constructing immunoassays to improve detection sensitivity and selectivity. Nanozymes exhibit high catalytic activity with tunability, easy preparation, high stability, and low cost. Due to these factors, nanozymes are gaining significant traction over natural enzymes, as they also eliminate the latter's defects. These advancements to improve immunoassays sensitivity further propel the growth of global immunoassay market.
Government Initiatives
Immunoassays are valuable tools used for various purpose such as disease diagnosis, research and development in biopharmaceuticals, including vaccines and gene and cell therapy, and drug monitoring. Due to its wide applications, governments around the globe have initiated several policies and programs, emphasizing the importance of technological advancements and improvements in immunoassay technique quality. Governments are investing billions of dollars in R&D to bring innovation in modern immunoassay diagnostic techniques.
For instance, in September 2023, the National Institute of Justice (NIJ) announced funding of $1.9 million to support forensic science research under its Public Labs R&E program. This funding helps NIJ to improve the examination and analysis of the most efficient, reliable, accurate, and cost-effective methods of analysis in the public forensic labs, including the development of a method for product and biological tissue analysis and assess cross-reactivity of immunoassay.
Increasing Volume of ELISA
Enzyme-linked immunosorbent assay (ELISA) is one of the most widely used immunoassay methods against HCoVs (Human Coronaviruses) and other viruses. Due to its ease of use with simple procedure, high throughput, rapid, high sensitivity, and good specificity, ELISA is gaining popularity among the major players. ELISA is a safe, eco-friendly, and cost-effective essay diagnostic procedure. Due to this, many major players are launching innovative techniques in ELISA to improve their product portfolios.
For instance, in October 2023, QIAGEN launched QuantiFERON-EBV RUO. This was designed to support research and development in EBV infection (Ebola Virus) and EBV-related malignancies. It uses QuantiFERON technology, along with ELISA detection system, to enable the researcher to study the immune response in the virus, which will further assist in improving the medical treatment against these viruses. These new launches and innovations in immunoassays are driving the global immunoassay market.
Growing Applications of Immunoassay
Immunoassay tests have a vast area of applications, including medical diagnostics, environmental testing, and food safety. Immunoassay tests are used for diagnosing infectious diseases, such as HIV, hepatitis, and tuberculosis, screening and monitoring for drugs abuse, and identifying and measuring allergens in food and environmental samples. They also gain traction as they provide rapid and accurate diagnostic results for point-of-care testing in different healthcare settings. Due to this, many market players are launching novel products in immunoassays to enhance their diagnostic products portfolio.
For instance, in May 2023, Beckman Coulter, a leader in clinical diagnostics, launched DxI 9000 Access Immunoassay Analyzer. This product has the potential to run up to 215 tests per hour. This technology has zero daily maintenance and will enable the healthcare professionals to improve throughput rates with great precision.
Future Market Scenario (2024-2031F)
Global immunoassay market is expected to grow tremendously in the coming years due to multiple factors. One of the primary drivers include an increasing prevalence of chronic and infectious diseases and a growing geriatric population. This will be further supported by rapid technological advancements and the integration of AI, resulting in accurate diagnosis and improved accuracy, especially for community-level surveillance. Moreover, government initiatives, policies, and programs are expected to enhance screening, which, in turn, will create a favorable market outlook. In line with this, increasing investments by public and private companies for research and development in their respective markets and collaborative ventures involving diagnostic device manufacturers and research institutions have spurred innovation leading to further growth of the global immunoassay market.
Report Scope
“Global Immunoassay Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global immunoassay market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, future market scenario, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031 |
|
Projected Growth Rate |
CAGR of 4.8% between 2024-2031 |
|
Revenue Forecast in 2031 |
USD 49.63 billion |
|
Segments Covered |
Product, Technique, Specimen, Application, End-user |
|
Regions Covered |
North America, South America, Europe, Asia-Pacific, Middle East and Africa |
|
Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Becton, Dickinson and Company, BioMérieux SA, Thermo Fisher Scientific Company, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Beckman Coulter, Inc. |
|
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, global immunoassay market has been segmented into the following categories:
· By Product
o Reagents & Kits
o Analyzers
o Software & Services
· By Technique
o Enzyme-Linked Immunosorbent Assays
o Rapid Tests
o Enzyme-Linked Immunospot
o Western Blotting
o Immuno-PCR
o Other Techniques
· By Specimen
o Blood
o Saliva
o Urine
o Others
o Cardiology
o Therapeutic Drug Monitoring
o Infectious Diseases
o Endocrinology
o Autoimmune Diseases
o Others
· By End-user
o Clinical Laboratories
o Pharmaceutical and Biotech Companies
o Blood Banks
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Key Players Landscape and Outlook
In the immunoassay industry, several public and private organizations are actively establishing strategic partnerships and distribution agreements to empower and strengthen each other’s resources, gain insights regarding new markets and advanced technologies, and expand their businesses across the globe. Many big players are undergoing mergers and acquisitions, and partnerships to enhance and strengthen their product portfolios. For instance, on July 2023, Beckman Coulter Diagnostics, which is a leader in clinical diagnostics, and Fujirebio, a pioneer in neurological markers and a leader in manufacturing In Vitro Diagnostic (IVD), announced a new strategic partnership to combine their respective immunoassay strengths to support clinical trials, therapeutic development, reimbursement, and routine clinical adoption in neurodegenerative diseases.
Key Players Operating in Global Immunoassay Market are:
· Abbott Laboratories
· F. Hoffmann-La Roche AG
· Becton, Dickinson and Company
· BioMérieux SA
· Thermo Fisher Scientific Company
· QuidelOrtho Corporation
· Bio-Rad Laboratories, Inc.
· Merck KGaA
· Beckman Coulter, Inc.
Markets and Data reports answer the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global immunoassay market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Future Outlook of Global Immunoassay Market
4. Executive Summary
5. Global Immunoassay Market Outlook, 2017-2031F
5.1. Market Size & Forecast
5.1.1.Value
5.1.2.Volume
5.2.1.Reagents & Kits
5.2.2.Analyzers
5.2.3.Software & Services
5.3. By Technique
5.3.1.Enzyme-Linked Immunosorbent Assays
5.3.2.Rapid Tests
5.3.3.Enzyme-Linked Immunospot
5.3.4.Western Blotting
5.3.5.Immuno-PCR
5.3.6.Other Techniques
5.4. By Specimen
5.4.1.Blood
5.4.2.Saliva
5.4.3.Urine
5.4.4.Others
5.5.1.Oncology
5.5.2.Cardiology
5.5.3.Therapeutic Drug Monitoring
5.5.4.Infectious Diseases
5.5.5.Endocrinology
5.5.6.Autoimmune Diseases
5.5.7.Others
5.6. By End-user
5.6.2.Clinical Laboratories
5.6.3.Pharmaceutical and Biotech Companies
5.6.4.Blood Banks
5.6.5.Others
5.7. By Region
5.7.1.North America
5.7.2.Europe
5.7.3.South America
5.7.4.Asia-Pacific
5.7.5.Middle East and Africa
5.8. By Company Market Share (%), 2023
6. Global Immunoassay Market Outlook, By Region, 2017-2031F
6.1. North America*
6.1.1. Market Size & Forecast
6.1.1.1. Value
6.1.1.2. Volume
6.1.2.1. Reagents & Kits
6.1.2.2. Analyzers
6.1.2.3. Software & Services
6.1.3. By Technique
6.1.3.1. Enzyme-Linked Immunosorbent Assays
6.1.3.2. Rapid Tests
6.1.3.3. Enzyme-Linked Immunospot
6.1.3.4. Western Blotting
6.1.3.5. Immuno-PCR
6.1.3.6. Others
6.1.4. By Specimen
6.1.4.1. Blood
6.1.4.2. Saliva
6.1.4.3. Urine
6.1.4.4. Others
6.1.5. By Application
6.1.5.1. Oncology
6.1.5.2. Cardiology
6.1.5.3. Therapeutic Drug Monitoring
6.1.5.4. Infectious Diseases
6.1.5.5. Endocrinology
6.1.5.6. Autoimmune Diseases
6.1.5.7. Others
6.1.6. By End-user
6.1.6.2. Clinical Laboratories
6.1.6.3. Pharmaceutical and Biotech Companies
6.1.6.4. Blood Banks
6.1.6.5. Others
6.1.7. United States*
6.1.7.1. Market Size & Forecast
6.1.7.1.1. Value
6.1.7.1.2. Volume
6.1.7.2. By Product
6.1.7.2.1. Reagents & Kits
6.1.7.2.2. Analyzers
6.1.7.2.3. Software & Services
6.1.7.3. By Technique
6.1.7.3.1. Enzyme-Linked Immunosorbent Assays
6.1.7.3.2. Rapid Tests
6.1.7.3.3. Enzyme-Linked Immunospot
6.1.7.3.4. Western Blotting
6.1.7.3.5. Immuno-PCR
6.1.7.3.6. Others
6.1.7.4. By Specimen
6.1.7.4.1. Blood
6.1.7.4.2. Saliva
6.1.7.4.3. Urine
6.1.7.4.4. Others
6.1.7.5. By Application
6.1.7.5.1. Oncology
6.1.7.5.2. Cardiology
6.1.7.5.3. Therapeutic Drug Monitoring
6.1.7.5.4. Infectious Diseases
6.1.7.5.5. Endocrinology
6.1.7.5.6. Autoimmune Diseases
6.1.7.5.7. Others
6.1.7.6. By End-user
6.1.7.6.1. Hospitals
6.1.7.6.2. Clinical Laboratories
6.1.7.6.3. Pharmaceutical and Biotech Companies
6.1.7.6.4. Blood Banks
6.1.7.6.5. Others
6.1.8. Canada
6.1.9. Mexico
*All segments will be provided for all regions and countries covered
6.2. Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 United Kingdom
6.2.5 Russia
6.2.6 Netherlands
6.2.7 Spain
6.2.8 Turkey
6.2.9 Poland
6.3. South America
6.3.1. Brazil
6.3.2. Argentina
6.4. Asia-Pacific
6.4.1. India
6.4.2. China
6.4.3. Japan
6.4.4. Australia
6.4.5. Vietnam
6.4.6. South Korea
6.4.7. Indonesia
6.4.8. Philippines
6.5. Middle East & Africa
6.5.1. Saudi Arabia
6.5.2. UAE
6.5.3. South Africa
7. Market Mapping, 2023
7.1. By Product
7.2. By Technique
7.3. By Specimen
7.4. By Application
7.5. By End-user
7.6. By Region
8. Macro Environment and Industry Structure
8.1. Supply Demand Analysis
8.2. Import Export Analysis
8.3. Value Chain Analysis
8.4. PESTEL Analysis
8.4.1. Political Factors
8.4.2. Economic System
8.4.3. Social Implications
8.4.4. Technological Advancements
8.4.5. Environmental Impacts
8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
8.5. Porter’s Five Forces Analysis
8.5.1. Supplier Power
8.5.2. Buyer Power
8.5.3. Substitution Threat
8.5.4. Threat from New Entrant
8.5.5. Competitive Rivalry
9. Market Dynamics
9.1. Growth Drivers
9.2. Growth Inhibitors (Challenges and Restraints)
10. Regulatory Framework and Innovation
10.1 Clinical Trials
10.2 Patent Landscape
10.3 Regulatory Approvals
10.4 Innovations/Emerging Technologies
11. Key Players Landscape
11.1. Competition Matrix of Top Five Market Leaders
11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4. SWOT Analysis (For Five Market Players)
11.5. Patent Analysis (If Applicable)
12. Pricing Analysis
13. Case Studies
14. Key Players Outlook
14.1.1. Company Details
14.1.2. Key Management Personnel
14.1.3. Products & Services
14.1.4. Financials (As reported)
14.1.5. Key Market Focus & Geographical Presence
14.1.6. Recent Developments
14.3. Siemens Healthineers
14.4. Becton, Dickinson and Company
14.5. BioMérieux SA
14.6. Thermo Fisher Scientific Company
14.7. QuidelOrtho Corporation
14.8. Bio-Rad Laboratories, Inc.
14.9. Merck KGaA
14.10. Beckman Coulter, Inc.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
15. Strategic Recommendations
16. About Us & Disclaimer
List of Figures
Figure 1. Global Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global Immunoassay Market Share (%), By Product, 2017-2031F
Figure 4. Global Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 5. Global Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 6. Global Immunoassay Market Share (%), By Application, 2017-2031F
Figure 7. Global Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 8. Global Immunoassay Market Share (%), By Region, 2017-2031F
Figure 9. North America Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 11. North America Immunoassay Market Share (%), By Product, 2017-2031F
Figure 12. North America Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 13. North America Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 14. North America Immunoassay Market Share (%), By Application, 2017-2031F
Figure 15. North America Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 16. North America Immunoassay Market Share (%), By Country, 2017-2031F
Figure 17. United States Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 19. United States Immunoassay Market Share (%), By Product, 2017-2031F
Figure 20. United States Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 21. United States Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 22. United States Immunoassay Market Share (%), By Application, 2017-2031F
Figure 23. United States Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 24. Canada Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 26. Canada Immunoassay Market Share (%), By Product, 2017-2031F
Figure 27. Canada Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 28. Canada Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 29. Canada Immunoassay Market Share (%), By Application, 2017-2031F
Figure 30. Canada Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 31. Mexico Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 33. Mexico Immunoassay Market Share (%), By Product, 2017-2031F
Figure 34. Mexico Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 35. Mexico Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 36. Mexico Immunoassay Market Share (%), By Application, 2017-2031F
Figure 37. Mexico Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 38. Europe Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 40. Europe Immunoassay Market Share (%), By Product, 2017-2031F
Figure 41. Europe Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 42. Europe Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 43. Europe Immunoassay Market Share (%), By Application, 2017-2031F
Figure 44. Europe Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 45. Europe Immunoassay Market Share (%), By Country, 2017-2031F
Figure 46. Germany Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 48. Germany Immunoassay Market Share (%), By Product, 2017-2031F
Figure 49. Germany Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 50. Germany Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 51. Germany Immunoassay Market Share (%), By Application, 2017-2031F
Figure 52. Germany Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 53. France Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 54. France Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 55. France Immunoassay Market Share (%), By Product, 2017-2031F
Figure 56. France Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 57. France Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 58. France Immunoassay Market Share (%), By Application, 2017-2031F
Figure 59. France Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 60. Italy Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 62. Italy Immunoassay Market Share (%), By Product, 2017-2031F
Figure 63. Italy Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 64. Italy Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 65. Italy Immunoassay Market Share (%), By Application, 2017-2031F
Figure 66. Italy Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 67. United Kingdom Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 69. United Kingdom Immunoassay Market Share (%), By Product, 2017-2031F
Figure 70. United Kingdom Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 71. United Kingdom Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 72. United Kingdom Immunoassay Market Share (%), By Application, 2017-2031F
Figure 73. United Kingdom Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 74. Russia Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 76. Russia Immunoassay Market Share (%), By Product, 2017-2031F
Figure 77. Russia Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 78. Russia Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 79. Russia Immunoassay Market Share (%), By Application, 2017-2031F
Figure 80. Russia Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 81. Netherlands Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 83. Netherlands Immunoassay Market Share (%), By Product, 2017-2031F
Figure 84. Netherlands Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 85. Netherlands Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 86. Netherlands Immunoassay Market Share (%), By Application, 2017-2031F
Figure 87. Netherlands Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 88. Spain Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 90. Spain Immunoassay Market Share (%), By Product, 2017-2031F
Figure 91. Spain Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 92. Spain Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 93. Spain Immunoassay Market Share (%), By Application, 2017-2031F
Figure 94. Spain Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 95. Turkey Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 97. Turkey Immunoassay Market Share (%), By Product, 2017-2031F
Figure 98. Turkey Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 99. Turkey Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 100. Turkey Immunoassay Market Share (%), By Application, 2017-2031F
Figure 101. Turkey Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 102. Poland Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 104. Poland Immunoassay Market Share (%), By Product, 2017-2031F
Figure 105. Poland Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 106. Poland Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 107. Poland Immunoassay Market Share (%), By Application, 2017-2031F
Figure 108. Poland Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 109. South America Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 111. South America Immunoassay Market Share (%), By Product, 2017-2031F
Figure 112. South America Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 113. South America Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 114. South America Immunoassay Market Share (%), By Application, 2017-2031F
Figure 115. South America Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 116. South America Immunoassay Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 119. Brazil Immunoassay Market Share (%), By Product, 2017-2031F
Figure 120. Brazil Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 121. Brazil Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 122. Brazil Immunoassay Market Share (%), By Application, 2017-2031F
Figure 123. Brazil Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 124. Argentina Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 126. Argentina Immunoassay Market Share (%), By Product, 2017-2031F
Figure 127. Argentina Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 128. Argentina Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 129. Argentina Immunoassay Market Share (%), By Application, 2017-2031F
Figure 130. Argentina Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 131. Asia-Pacific Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 133. Asia-Pacific Immunoassay Market Share (%), By Product, 2017-2031F
Figure 134. Asia-Pacific Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 135. Asia-Pacific Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 136. Asia-Pacific Immunoassay Market Share (%), By Application, 2017-2031F
Figure 137. Asia- Pacific Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 138. Asia-Pacific Immunoassay Market Share (%), By Country, 2017-2031F
Figure 139. India Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 140. India Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 141. India Immunoassay Market Share (%), By Product, 2017-2031F
Figure 142. India Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 143. India Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 144. India Immunoassay Market Share (%), By Application, 2017-2031F
Figure 145. India Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 146. China Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 147. China Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 148. China Immunoassay Market Share (%), By Product, 2017-2031F
Figure 149. China Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 150. China Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 151. China Immunoassay Market Share (%), By Application, 2017-2031F
Figure 152. China Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 153. Japan Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 155. Japan Immunoassay Market Share (%), By Product, 2017-2031F
Figure 156. Japan Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 157. Japan Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 158. Japan Immunoassay Market Share (%), By Application, 2017-2031F
Figure 159. Japan Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 160. Australia Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 162. Australia Immunoassay Market Share (%), By Product, 2017-2031F
Figure 163. Australia Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 164. Australia Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 165. Australia Immunoassay Market Share (%), By Application, 2017-2031F
Figure 166. Australia Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 167. Vietnam Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 169. Vietnam Immunoassay Market Share (%), By Product, 2017-2031F
Figure 170. Vietnam Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 171. Vietnam Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 172. Vietnam Immunoassay Market Share (%), By Application, 2017-2031F
Figure 173. Vietnam Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 174. South Korea Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 176. South Korea Immunoassay Market Share (%), By Product, 2017-2031F
Figure 177. South Korea Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 178. South Korea Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 179. South Korea Immunoassay Market Share (%), By Application, 2017-2031F
Figure 180. South Korea Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 181. Indonesia Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 183. Indonesia Immunoassay Market Share (%), By Product, 2017-2031F
Figure 184. Indonesia Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 185. Indonesia Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 186. Indonesia Immunoassay Market Share (%), By Application, 2017-2031F
Figure 187. Indonesia Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 188. Philippines Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 190. Philippines Immunoassay Market Share (%), By Product, 2017-2031F
Figure 191. Philippines Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 192. Philippines Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 193. Philippines Immunoassay Market Share (%), By Application, 2017-2031F
Figure 194. Philippines Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 195. Middle East & Africa Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 197. Middle East & Africa Immunoassay Market Share (%), By Product, 2017-2031F
Figure 198. Middle East & Africa Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 199. Middle East & Africa Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 200. Middle East & Africa Immunoassay Market Share (%), By Application, 2017-2031F
Figure 201. Middle East & Africa Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 202. Middle East & Africa Immunoassay Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 205. Saudi Arabia Immunoassay Market Share (%), By Product, 2017-2031F
Figure 206. Saudi Arabia Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 207. Saudi Arabia Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 208. Saudi Arabia Immunoassay Market Share (%), By Application, 2017-2031F
Figure 209. Saudi Arabia Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 210. UAE Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 212. UAE Immunoassay Market Share (%), By Product, 2017-2031F
Figure 213. UAE Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 214. UAE Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 215. UAE Immunoassay Market Share (%), By Application, 2017-2031F
Figure 216. UAE Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 217. South Africa Immunoassay Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa Immunoassay Market, By Volume, In Million Units, 2017-2031F
Figure 219. South Africa Immunoassay Market Share (%), By Product, 2017-2031F
Figure 220. South Africa Immunoassay Market Share (%), By Technique, 2017-2031F
Figure 221. South Africa Immunoassay Market Share (%), By Specimen, 2017-2031F
Figure 222. South Africa Immunoassay Market Share (%), By Application, 2017-2031F
Figure 223. South Africa Immunoassay Market Share (%), By End-user, 2017-2031F
Figure 224. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Technique Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Specimen Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
Who are the key players operating in the global immunoassay market?
What are the major factors influencing the growth of the global immunoassay market?
What are the regions covered in the final report for global immunoassay market?
What is the market size and growth rate of the global immunoassay market?
See Related Reports
Global Female Urination Devices Market Assessment, Opportunities and Forecast, 2017-2031F
Global female urination devices market is projected to witness a CAGR of 10.18% during the forecast period 2024-2031, growing from USD 2.72 billion in 2023 to USD 5.91 billion in 2031. ....Read More
Published on
May 2024
4,500
Global Packaged Coconut Water Market Assessment, Opportunities and Forecast, 2017-2031F
Global packaged coconut water market is projected to witness a CAGR of 11.24% during the forecast period 2024-2031, growing from USD 1538.6 million in 2023 to USD 3608.42 million in 2031. ....Read More
Published on
May 2024
4,500
Global Almond Market Assessment, Opportunities and Forecast, 2017-2031F
Global almond flour market is projected to witness a CAGR of 7.52% during the forecast period 2024-2031, growing from USD 1.51 billion in 2023 to USD 2.7 billion in 2031. ....Read More
Published on
May 2024
4,500
India Crop Insurance Market Assessment, Opportunities and Forecast, 2018-2032F
India crop insurance market is projected to witness a CAGR of 7.62% during the forecast period FY2025-FY2032, growing from USD 4.56 billion in FY2024 to USD 8.21 billion in FY2032. ....Read More
Published on
May 2024
3,300
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
